• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌肝转移的可切除边界:现状与未来展望

Borderline resectable for colorectal liver metastases: Present status and future perspective.

作者信息

Kitano Yuki, Hayashi Hiromitsu, Matsumoto Takashi, Kinoshita Shotaro, Sato Hiroki, Shiraishi Yuta, Nakao Yosuke, Kaida Takayoshi, Imai Katsunori, Yamashita Yo-Ichi, Baba Hideo

机构信息

Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.

出版信息

World J Gastrointest Surg. 2021 Aug 27;13(8):756-763. doi: 10.4240/wjgs.v13.i8.756.

DOI:10.4240/wjgs.v13.i8.756
PMID:34512899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8394381/
Abstract

Surgical resection for colorectal liver metastases (CRLM) may offer the best opportunity to improve prognosis. However, only about 20% of CRLM cases are indicated for resection at the time of diagnosis (initially resectable), and the remaining cases are treated as unresectable (initially unresectable). Thanks to recent remarkable developments in chemotherapy, interventional radiology, and surgical techniques, the resectability of CRLM is expanding. However, some metastases are technically resectable but oncologically questionable for upfront surgery. In pancreatic cancer, such cases are categorized as "borderline resectable", and their definition and treatment strategies are explicit. However, in CRLM, although various poor prognosis factors have been identified in previous reports, no clear definition or treatment strategy for borderline resectable has yet been established. Since the efficacy of hepatectomy for CRLM was reported in the 1970s, multidisciplinary treatment for unresectable cases has improved resectability and prognosis, and clarifying the definition and treatment strategy of borderline resectable CRLM should yield further improvement in prognosis. This review outlines the present status and the future perspective for borderline resectable CRLM, based on previous studies.

摘要

结直肠癌肝转移(CRLM)的手术切除可能是改善预后的最佳机会。然而,在诊断时,只有约20%的CRLM病例适合切除(初始可切除),其余病例则被视为不可切除(初始不可切除)。由于近年来化疗、介入放射学和手术技术的显著发展,CRLM的可切除性正在扩大。然而,一些转移灶在技术上可切除,但对于 upfront 手术在肿瘤学上存在疑问。在胰腺癌中,此类病例被归类为“边缘可切除”,其定义和治疗策略是明确的。然而,在CRLM中,尽管先前的报告已经确定了各种预后不良因素,但尚未建立明确的边缘可切除定义或治疗策略。自20世纪70年代报道了CRLM肝切除术的疗效以来,不可切除病例的多学科治疗提高了可切除性和预后,明确边缘可切除CRLM的定义和治疗策略应能进一步改善预后。本综述基于先前的研究概述了边缘可切除CRLM的现状和未来展望。

相似文献

1
Borderline resectable for colorectal liver metastases: Present status and future perspective.结直肠癌肝转移的可切除边界:现状与未来展望
World J Gastrointest Surg. 2021 Aug 27;13(8):756-763. doi: 10.4240/wjgs.v13.i8.756.
2
BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.BRAF V600E 可能决定“技术上可切除”结直肠癌肝转移的“肿瘤可切除性”。
Cancer Med. 2021 Oct;10(20):6998-7011. doi: 10.1002/cam4.4227. Epub 2021 Sep 18.
3
Objective Definition and Optimized Strategy for "Biologically Borderline Resectable" Colorectal Liver Metastases.“生物学上临界可切除”结直肠癌肝转移的客观定义及优化策略
World J Surg. 2023 Nov;47(11):2834-2845. doi: 10.1007/s00268-023-07133-y. Epub 2023 Aug 4.
4
Multidisciplinary approach of liver metastases from colorectal cancer.结直肠癌肝转移的多学科治疗方法。
Ann Gastroenterol Surg. 2019 Jan 14;3(1):50-56. doi: 10.1002/ags3.12227. eCollection 2019 Jan.
5
Proposal of "borderline resectable" colorectal liver metastases based on analysis of risk factors for early surgical failure.基于早期手术失败风险因素分析的“可切除边缘”结直肠癌肝转移的提议
Surg Today. 2025 Mar;55(3):425-433. doi: 10.1007/s00595-024-02920-z. Epub 2024 Aug 19.
6
New definition of borderline resectable colorectal liver metastasis based on prognostic outcomes.基于预后结果的结直肠癌肝转移边界可切除新定义。
Langenbecks Arch Surg. 2024 Oct 8;409(1):301. doi: 10.1007/s00423-024-03492-9.
7
Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.荷兰结直肠肿瘤学组肝脏转移专家组可切除性评估的结果。
J Am Coll Surg. 2019 Dec;229(6):523-532.e2. doi: 10.1016/j.jamcollsurg.2019.08.1445. Epub 2019 Sep 11.
8
Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.泛欧调查:初诊可切除结直肠癌肝转移患者的当前治疗策略。
HPB (Oxford). 2024 May;26(5):639-647. doi: 10.1016/j.hpb.2024.01.007. Epub 2024 Jan 29.
9
Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature.结直肠癌肝转移的新辅助化疗:文献综述
World J Gastrointest Oncol. 2021 Sep 15;13(9):1043-1061. doi: 10.4251/wjgo.v13.i9.1043.
10
Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.同步性结直肠癌肝转移:“外科医生作为肿瘤学家”的视角
Minerva Chir. 2013 Feb;68(1):49-76.

引用本文的文献

1
-Beppu Classification: A New Recurrence Risk Classification System Incorporating the Beppu Score and Status for Colorectal Liver Metastases.别府分类:一种结合别府评分和结直肠癌肝转移状态的新复发风险分类系统。
Cancers (Basel). 2025 Feb 14;17(4):640. doi: 10.3390/cancers17040640.
2
The Effect of Hepatic Surgical Margins of Colorectal Liver Metastases on Prognosis: A Systematic Review and Meta-Analysis.结直肠癌肝转移肝手术切缘对预后的影响:一项系统评价与Meta分析
J Clin Med. 2024 Dec 19;13(24):7776. doi: 10.3390/jcm13247776.
3
Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023.新型全身治疗时代肝细胞癌的肿瘤可切除性标准:日本肝癌协会和日本肝胆胰外科学会2023年专家共识声明
Liver Cancer. 2024 Mar 29;13(6):0-10. doi: 10.1159/000538627. eCollection 2024 Dec.
4
RAS mutant transverse colon cancer with multiple liver metastases achieving long-term disease-free survival with postoperative maintenance therapy with aflibercept + FOLFIRI and four repeated radical resections: a case report.RAS突变型横结肠癌伴多发肝转移经阿柏西普联合FOLFIRI术后维持治疗及四次重复根治性切除实现长期无病生存:一例报告
Surg Case Rep. 2024 Oct 8;10(1):231. doi: 10.1186/s40792-024-02033-2.
5
Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases.结直肠癌肝转移精准手术面临的挑战与机遇
Cancers (Basel). 2024 Jun 28;16(13):2379. doi: 10.3390/cancers16132379.
6
Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale.利用自然语言处理技术从大规模放射学报告中推断转移性疾病部位。
JCO Clin Cancer Inform. 2024 May;8:e2300122. doi: 10.1200/CCI.23.00122.
7
Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.结直肠癌肝转移灶肝切除术后的长期生存:伊朗的一项单中心研究
BMC Surg. 2024 May 3;24(1):131. doi: 10.1186/s12893-024-02420-4.
8
ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis.循环肿瘤DNA作为可切除性结直肠癌肝转移预后生物标志物的系统评价与Meta分析
Open Life Sci. 2023 May 19;18(1):20220615. doi: 10.1515/biol-2022-0615. eCollection 2023.

本文引用的文献

1
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.可切除及临界可切除胰腺癌的术前放化疗与直接手术对比:荷兰随机III期PREOPANC试验结果
J Clin Oncol. 2020 Jun 1;38(16):1763-1773. doi: 10.1200/JCO.19.02274. Epub 2020 Feb 27.
2
ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO.ALPPS 相较于 TSH 可改善结直肠癌肝转移患者的生存:来自随机对照试验 LIGRO 的生存分析。
Ann Surg. 2021 Mar 1;273(3):442-448. doi: 10.1097/SLA.0000000000003701.
3
Conversion Chemotherapy With a Modified FLOX Regimen for Borderline or Unresectable Liver Metastases From Colorectal Cancer: An Alternative for Limited-Resources Settings.采用改良FLOX方案的转化化疗用于结直肠癌的边缘性或不可切除肝转移:资源有限地区的一种替代方案
J Glob Oncol. 2019 Sep;5:1-6. doi: 10.1200/JGO.19.00180.
4
Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.可切除结直肠肝转移患者新辅助化疗的最佳适应证标准。
World J Surg Oncol. 2019 Jun 13;17(1):100. doi: 10.1186/s12957-019-1641-5.
5
Multidisciplinary approach of liver metastases from colorectal cancer.结直肠癌肝转移的多学科治疗方法。
Ann Gastroenterol Surg. 2019 Jan 14;3(1):50-56. doi: 10.1002/ags3.12227. eCollection 2019 Jan.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial).ALPPS 相较于传统两阶段肝切除术可提高晚期结直肠癌肝转移患者的可切除性:一项来自斯堪的纳维亚多中心随机对照试验(LIGRO 试验)的结果。
Ann Surg. 2018 May;267(5):833-840. doi: 10.1097/SLA.0000000000002511.
8
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.《胰腺导管腺癌临床实践指南(2017 年第 2 版)》,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.
9
ASCO 2016 - update colorectal liver metastases.美国临床肿瘤学会2016年 - 结直肠癌肝转移的最新进展
Memo. 2017;10(2):103-105. doi: 10.1007/s12254-016-0308-y. Epub 2017 Jan 17.
10
Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.结直肠肝转移及合并肝外疾病患者的治愈潜力。
J Surg Oncol. 2017 Mar;115(4):488-496. doi: 10.1002/jso.24539. Epub 2017 Mar 31.